723 related articles for article (PubMed ID: 17415756)
1. Quantitative assessment of scaffold and growth factor-mediated repair of critically sized bone defects.
Oest ME; Dupont KM; Kong HJ; Mooney DJ; Guldberg RE
J Orthop Res; 2007 Jul; 25(7):941-50. PubMed ID: 17415756
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly(L-lactic-co-glycolic acid) scaffold.
Jeon O; Song SJ; Kang SW; Putnam AJ; Kim BS
Biomaterials; 2007 Jun; 28(17):2763-71. PubMed ID: 17350678
[TBL] [Abstract][Full Text] [Related]
3. Improving bone formation in a rat femur segmental defect by controlling bone morphogenetic protein-2 release.
Brown KV; Li B; Guda T; Perrien DS; Guelcher SA; Wenke JC
Tissue Eng Part A; 2011 Jul; 17(13-14):1735-46. PubMed ID: 21338268
[TBL] [Abstract][Full Text] [Related]
4. Orthotopic bone formation by implantation of apatite-coated poly(lactide-co-glycolide)/hydroxyapatite composite particulates and bone morphogenetic protein-2.
Kim SS; Gwak SJ; Kim BS
J Biomed Mater Res A; 2008 Oct; 87(1):245-53. PubMed ID: 18181112
[TBL] [Abstract][Full Text] [Related]
5. BMP-silk composite matrices heal critically sized femoral defects.
Kirker-Head C; Karageorgiou V; Hofmann S; Fajardo R; Betz O; Merkle HP; Hilbe M; von Rechenberg B; McCool J; Abrahamsen L; Nazarian A; Cory E; Curtis M; Kaplan D; Meinel L
Bone; 2007 Aug; 41(2):247-55. PubMed ID: 17553763
[TBL] [Abstract][Full Text] [Related]
6. Delivery vehicle effects on bone regeneration and heterotopic ossification induced by high dose BMP-2.
Krishnan L; Priddy LB; Esancy C; Klosterhoff BS; Stevens HY; Tran L; Guldberg RE
Acta Biomater; 2017 Feb; 49():101-112. PubMed ID: 27940197
[TBL] [Abstract][Full Text] [Related]
7. Design, fabrication and in vitro evaluation of a novel polymer-hydrogel hybrid scaffold for bone tissue engineering.
Igwe JC; Mikael PE; Nukavarapu SP
J Tissue Eng Regen Med; 2014 Feb; 8(2):131-42. PubMed ID: 22689304
[TBL] [Abstract][Full Text] [Related]
8. Optimized bone regeneration based on sustained release from three-dimensional fibrous PLGA/HAp composite scaffolds loaded with BMP-2.
Fu YC; Nie H; Ho ML; Wang CK; Wang CH
Biotechnol Bioeng; 2008 Mar; 99(4):996-1006. PubMed ID: 17879301
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of bone growth by sustained delivery of recombinant human bone morphogenetic protein-2 in a polymeric matrix.
Woo BH; Fink BF; Page R; Schrier JA; Jo YW; Jiang G; DeLuca M; Vasconez HC; DeLuca PP
Pharm Res; 2001 Dec; 18(12):1747-53. PubMed ID: 11785696
[TBL] [Abstract][Full Text] [Related]
10. An in vivo study on the effect of scaffold geometry and growth factor release on the healing of bone defects.
Yilgor P; Yilmaz G; Onal MB; Solmaz I; Gundogdu S; Keskil S; Sousa RA; Reis RL; Hasirci N; Hasirci V
J Tissue Eng Regen Med; 2013 Sep; 7(9):687-96. PubMed ID: 22396311
[TBL] [Abstract][Full Text] [Related]
11. Biodegradable composite scaffolds incorporating an intramedullary rod and delivering bone morphogenetic protein-2 for stabilization and bone regeneration in segmental long bone defects.
Henslee AM; Spicer PP; Yoon DM; Nair MB; Meretoja VV; Witherel KE; Jansen JA; Mikos AG; Kasper FK
Acta Biomater; 2011 Oct; 7(10):3627-37. PubMed ID: 21757034
[TBL] [Abstract][Full Text] [Related]
12. Use of a bioactive scaffold for the repair of bone defects in a novel reproducible vertebral body defect model.
Liang H; Wang K; Shimer AL; Li X; Balian G; Shen FH
Bone; 2010 Aug; 47(2):197-204. PubMed ID: 20580872
[TBL] [Abstract][Full Text] [Related]
13. A biodegradable porous composite scaffold of PGA/beta-TCP for bone tissue engineering.
Cao H; Kuboyama N
Bone; 2010 Feb; 46(2):386-95. PubMed ID: 19800045
[TBL] [Abstract][Full Text] [Related]
14. Combination of platelet-rich plasma with polycaprolactone-tricalcium phosphate scaffolds for segmental bone defect repair.
Rai B; Oest ME; Dupont KM; Ho KH; Teoh SH; Guldberg RE
J Biomed Mater Res A; 2007 Jun; 81(4):888-99. PubMed ID: 17236215
[TBL] [Abstract][Full Text] [Related]
15. Boron containing poly-(lactide-co-glycolide) (PLGA) scaffolds for bone tissue engineering.
Doğan A; Demirci S; Bayir Y; Halici Z; Karakus E; Aydin A; Cadirci E; Albayrak A; Demirci E; Karaman A; Ayan AK; Gundogdu C; Sahin F
Mater Sci Eng C Mater Biol Appl; 2014 Nov; 44():246-53. PubMed ID: 25280703
[TBL] [Abstract][Full Text] [Related]
16. Human osteoprogenitor bone formation using encapsulated bone morphogenetic protein 2 in porous polymer scaffolds.
Yang XB; Whitaker MJ; Sebald W; Clarke N; Howdle SM; Shakesheff KM; Oreffo RO
Tissue Eng; 2004; 10(7-8):1037-45. PubMed ID: 15363161
[TBL] [Abstract][Full Text] [Related]
17. Functional restoration of critically sized segmental defects with bone morphogenetic protein-2 and heparin treatment.
Johnson MR; Boerckel JD; Dupont KM; Guldberg RE
Clin Orthop Relat Res; 2011 Nov; 469(11):3111-7. PubMed ID: 21863396
[TBL] [Abstract][Full Text] [Related]
18. Bone regeneration using photocrosslinked hydrogel incorporating rhBMP-2 loaded 2-N, 6-O-sulfated chitosan nanoparticles.
Cao L; Werkmeister JA; Wang J; Glattauer V; McLean KM; Liu C
Biomaterials; 2014 Mar; 35(9):2730-42. PubMed ID: 24438908
[TBL] [Abstract][Full Text] [Related]
19. Hydrogel-based Delivery of rhBMP-2 Improves Healing of Large Bone Defects Compared With Autograft.
Krishnan L; Priddy LB; Esancy C; Li MT; Stevens HY; Jiang X; Tran L; Rowe DW; Guldberg RE
Clin Orthop Relat Res; 2015 Sep; 473(9):2885-97. PubMed ID: 25917422
[TBL] [Abstract][Full Text] [Related]
20. Repair of rat cranial bone defects with nHAC/PLLA and BMP-2-related peptide or rhBMP-2.
Li J; Hong J; Zheng Q; Guo X; Lan S; Cui F; Pan H; Zou Z; Chen C
J Orthop Res; 2011 Nov; 29(11):1745-52. PubMed ID: 21500252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
